Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc. (OMIC) priced its initial public offering on May 28, 2021 at $22.00 per share, raising $224.4M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.53B. Gunderson Dettmer advised the company and Cooley advised the underwriters.

Singular Genomics Systems, Inc. develops genomic sequencing platforms, along with novel applications and sample-to-result workflows. Its stated aim is fast, flexible and efficient sequencing for science and medicine, including multiomic analysis of DNA, RNA and proteins.

Status

IPO

Ticker

OMIC

Exchange

Nasdaq Global Select

Priced

May 28, 2021

IPO price

$22.00

Raised

$224.4M

Market cap at IPO price

$1.53B

First filed

May 7, 2021

Company counsel

Gunderson Dettmer

Underwriters' counsel

Cooley

Sector

Industrials & materials

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.